Stockreport

How Recent Developments Are Rewriting the Story for Sangamo Therapeutics [Yahoo! Finance]

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com
PDF Following its latest earnings and regulatory guidance, Sangamo Therapeutics has seen its fair value estimate hold steady at $3.25 per share, while its discount rate tick [Read more]